About US
Contact us
-
WHO says China complying with vaccine regulation standardsThe latest World Health Organization (WHO) assessment shows China is complying with international standards for vaccine regulation, a WHO official announced in Beijing Tuesday (March 1, 2011). Chin2011/3/7
-
FDA Takes Action to Remove Unapproved Drugs from US MarketThe US Food and Drug Administration (FDA) has initiated action against companies that manufacture, distribute or market certain unapproved prescription oral cough, cold, and allergy products. Unap2011/3/7
-
Roche, OraSure receive FDA 510(k) clearance for Oral Fluid Drug Testing SystemOraSure Technologies, Inc. (Nasdaq:OSUR) and Roche announced today that the U.S. Food and Drug Administration ("FDA") has granted the Companies 510(k) clearance on four homogeneous fully automated ora2011/3/7
-
Evonik finalizes acquisition of Boehringer Ingelheim’s RESOMER® business●Extending its technology base to increase value creation and boost growth ●Strengthening its position as a strategic partner to the pharmaceuticals industry Evonik Industries formally acquired t2011/3/2
-
SFDA held videoconference on carrying out Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition)On February 25, 2011, the State Food and Drug Administration (SFDA) held a videoconference on carrying out Good Manufacturing Practice for Pharmaceutical Products (2010 revised edition) (hereinafter r2011/3/2
-
‘Armor’ May Improve Drug-Ferrying Polymer VesiclesCould extend drug delivery time or mute immune response Adding a layer or layers of nanoparticles to the outside of polymer vesicles might improve the hollow particles’ ability to deliver drugs, re2011/3/1
-
FujiFilm to Acquire Merck Biologic UnitsFujiFilm has announced plans to acquire the equity interests in two biological drug manufacturing units of Merck. The Japanese firm will acquire UK-based MSD Biologics and US-based Diosynth RTP, w2011/3/1
-
Bayer and Onyx Initiate Nexavar TrialBayer HealthCare and Onyx Pharmaceuticals have begun enrolling patients in a Phase III trial in order to evaluate Nexavar tablets in combination with oral chemotherapeutic capecitabine. The trial2011/2/28
-
NICE Advises Against Using Avastin as a First-Line Breast Cancer TreatmentBevacizumab, also known as Avastin, should not be used as a first-line treatment for people with metastatic breast cancer, the UK's National Institute for Health and Clinical Excellence (NICE) has sai2011/2/28
-
Avastin debate spills over until June FDA hearingBy Dr Ananya Mandal, MD The U.S. Food and Drug Administration have granted Roche a hearing in June to defend the cancer treatment Avastin. The hearing would examine the effectiveness of the drug in2011/2/28